Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Lupus > Lupus > Flashcards

Lupus Flashcards

1
Q

DLE
who
peak onset
Associations

A

F>M
4th decade in F, later in males
C2 deficiency in females associated.
14-26% raynauds, 30% anaemia, leukopenia, thrombocytopenia
26% false +ve syphilis, 17% RF +ve
1/3 alopecia
20% elevated ESR, increase in serum globulins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Disseminated DLE
Who gets it
What does it look like

A

Women, who usually smoke
Persistent, resistant to therapy
May look like papulosquamous SCLE but scarring occurs
reticulate telangiectasia
LE gyratum repents: associated with underlying malignancy, negative lupus band.
Swindling of fingers+ hyperextension of distal phalanges

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Factors associated with onset of DLE

A

Trauma, stress, UV exposure, Drugs , seasonal (summer> winter, premenstrual

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Autoantibodies in DLE

A

5-60% +ve ANA (homogenous> speckled)
More common in long disease, extensive, with raynauds, joint pains, chilblains
0.-21% antidsDNA, 20% ssDNA (may represent widespread and progressive disease), 10% Ro Abs (no increased risk of SCLE), high incidence of antithyroid, parental cell Abs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

DLE
Nails
Eyes
Mucous membranes

A

Nails: subungual hyperkeratosis, redblue nail plate, longitudinal striae
Mucous membranes 24% involvement, LP like lesions, buccal mucosa, thickened rough lips, oral lesions may resemble leukoplakia
Eye: velvety oedema, redness of conjunctiva. More common lower eyelids esp lateral 1/3. May be associated with scarring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Chillblain lupus
Who
Progression to SLE
Abs

A

Smokers, can occur years post DLE, and persist with tx when DLE remits.
Usually precipitated by pregnancy
Some may have cryofibrinogenemia or cold agglutinins
Neg lupus band
Usually Ro +ve
15% get SLE, more common if develops DLE at same time and with EM.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Treatment of DLE

A

General measures
- psyche, camouflage, photoprotection
Topical
- potent topical steroids CS, often under occlusion
-IL CS, CO2 laser, PDL for telangiectasia
Oral
- nifedipine for raynauds
Pred for severe 0.5mg/kg, taper over 6/52
HCQ 200mg bd then reduce, most respond by 6/.52
stop smoking
Can use thalidomide 100mg/day, cyclophosphamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

DDx of DLE

A 
Morphea, LS, LP
Jessners/REM
Lupus vulgaris
Rosacea
NLD
Chilblain
PMLE
Blooms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Prognosis of DLE

A 
SCC in 3.3%, scalp, ears, lip, nose >20 years
Scarring 57%
scarring alopecia 35%
Premenstrual flare 20%
50% complete remission
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Associations of DLE that make it more likely to be difficult to treat

A

raynauds, scalp, chilblain like lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lupus panniculitis
% with DLE clinically and histologically
How does it heal

A

3-5% DLE clinically, 30% histologically

Heals with anetoderma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Histology of lupus panniculitis

A

Epidermal atrophy, follicular plugging, hydropic degeneration of the basal layer. Lymphocytes around appendages and vessels in mid derma. Hyalinisation around fat cells. Lower dermal + SC necrobiosis with some vasculitis. Popular panniculitis. Fibrous spate and lymphoid folliculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Lupus panniculitis - associations

A

Trauma, biopsy, EMG, monoclonal gammopathy, thrombocytopenic purport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Usual sites of lupus panniculitis

A

Face, proximal extremities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Concomitant SLE in lupus panniculitis

A

10-20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What do you have to histologically exclude from lupus pannicullitis

A

Subcutaneous panniculitis like T cell lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

T/F immune deposits occur in DEJ in lupus panniculitis

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

ABs in Rowell’s

A

Speckled ANA, RF, anti La (SSB)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

LE hypertrophicus et profundus

A

violaceous, scaly, tender lesions with a warty hypertrophic surface with scale and a brown-black tar like plaque.
Extensive serological abnormalities
Can resemble thrombophlebitis + calcification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

% of DLE that progresses to SLE

A

Rook 5% (22% disseminated, 1.2% head and neck)
BJD 16% progression within 3 years of Dx
Bologna 5-10%
Females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Does SCLE scar

A

Not usually, pigment changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Drugs and SCLE

A

Griseofulvin, Antihistamines, Terbinafine, calcium channel blockers, HCT, NSAIDS, PPIs, antitnf.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

% of SCLE with anti-ro

A

70% more likely if on face

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

ARA criteria (old for SLE)

A

ARA criteria - SOAP BRAIN MD (4 of 11)
• Serositis (pleuritis/pericarditis)
• Oral ulcers (painless)
• Arthritis (2 or more peripheral joints – tenderness, swelling or effusion)
• Photosensitivity
• Blood (haemolytic anaemia with reticulocytosis, leukopenia 0.5g/day or more than 3+ /casts)
• Antinuclear antibodies
• Immunological disorder (LE cells or anti DNA or anti-Sm ab or antiphospholiopid abs (anticardiolipin, lupus anticoagulant, false +ve syphilis – longer than 6 months)
• Neurological disorder (seizures/psychosis)
• Malar rash (fixed erythema, spares nasolabial)
• Discoid rash (follicular plugs, atrophic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Most specific autoantibodies for SLE

A

antidsDNA and antiSmAbs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Ix for suspected SLE

A
  • Examination: specific cutaneous lesions, non specific cutaneous lesions, lymphadenopathy, arthritis
  • Histology +/- lupus band
  • ANA with profile (anti-dsDNA, -Sm)
  • Urinalysis
  • eLFTS, FBC
  • ESR
  • C3, C4
  • antiphospholipids
  • G6PD pre treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Tx SLE

A

Photoprotection
o UVB is biggest problem (midday sun is high in UVB)
Topicals
o Topicals or IL steroids, tacrolimus +/- keratolytics
Systemics
o HCQ 6.5mg/kg/day +/- quinacrine (can turn skin yellow). Takes 2-3/12 for efficacy to be appreciated and several more months for maximal effect.  Smokers do not respond as well
o CS, AZA, leflunomide, MMF
o Pulse cyclophosphamide +/- pulse CS
o Dapsone for bullous LE

28
Q

Treatment of lupus panniculitis

A

clobetasol under occlusion, HCQ, ILCS, oral thalidomide

29
Q

Tx of SCLE

A

photoprotection
Topical or IL CS, tacrolimus
HCQ, oral CS or methylpred
acitretin, isotretinoin, capstone, MTX, thalidomide, IFNalpha, MMF

30
Q

NEW SLE criteria 4/17

A 
At least 1 clinical + 1 immunological
Clinical: 
ACLE or SCLE
Chronic cutaneous lupus
Non scarring alopecia
Oral or nasal ulcers
Joint disease
serositis
Renal 
Neurological
Haemolytic anaemia
Leukopenia or lymphopenia
Thrombocytopenia

Immunological:
ANA, antidsdna, anti-SM, antiphopholipid, low C3,C4, low CH50, direct cooks in absence of haemolytic anaemia

31
Q

Antiphospholipids

A

Lupus anticoagulant
anticardiolipin
B2 glycoprotein

32
Q

Antiphospholipid syndrome associated with

A

Libman sacks endocarditis, MI, valvular heart disease, a vascular necrosis
Thrombophlebitis, purport, lively, leg ulcers, gangrene, subungual splinter haemorrhages

33
Q

HLA for annular phenotype of SCLE

A

HLA-DR3 (B8, other)

34
Q

SCLE autoantibodies

A

60% homogenous ANA, 80% antiRo SSA, 16% anticardiolipin Ab

35
Q

Histo of SCLE cf to DLE

A

More epidermal atrophy,k less hyperkeratosis, less BM thickening, less follicular plugging, and inflammatory infiltration
More basal vascular change, dermal oedema and mucin

36
Q

DIF of SCLE

A

More positive in papulosqumous 88% > angular 29%
Overall 60%
Granular in cytoplasm, nuclear of basal keratinocytes and in epidermis (unlike other variants)

37
Q 
Neonatal lupus 
% with skin lesions
Precipitated by..
Scarring?
Residual lesions?
A

50%
UV, phototherapy for jaundice
Improves in 1st few months, resolves without scarring by 12/12.
May get residual telangiectasia, dyspigmentation ,atrophy, atrophic scarring.

38
Q 
Neonatal lupus
RIsk of :
Heart block
Pacing
Dilated cardiomyopathy
Thrombocytopenia
Mortality
A 
Heart block 60%
Pacing 50%
Dilated cardiomyopathy 20%
Thrombocytopenia 20% (transient)
Mortality 20%
39
Q

Other non haem or cardiac association with neonatal lupus

A

Liver: neonatal hepatitis, hepatomegaly + splenomegaly.

40
Q

Ix of neonatal lupus

A

FBC, elfts - thrombocytopenia and liver involvement
ECG, echo
Cardiology review
If steroids given first 16/40, no conduction defects
Harm review - may need prod 2mg/kg/day

41
Q

Risk of NLE in +ve Ro/SSA

A

2% if mother has no connective its use disease or previous hx of NLE
25% if previously NLE child

42
Q

Precipitate of SLE

A

UV
Sprouts, seeds, alfalfa, heavy metals (cadmium, mercury, gold)
Infection
Premenstrual flare in 20%
Drugs eg hydralazine, procainamide, TNFalpha, penicillamine, isoniazid, minocytcline.

43
Q

Poor prognostic factors of SLE

A

Renal involvement more organs, males, Asians+ black, arthritis, antiphospholipid, thrombocytopenia, haemolytic anaemia and CNS involvement.

44
Q

Good prognostic factors for SLE

A

CS, early Dx, decrease stress and drugs such as sulphonamides, control of infection with Abs

45
Q

SLE usual initial presentation

% with rash

A

58% articular
14% cutaneous
80% will have a rash

46
Q

Clinical skin features of SLE

A

Specific (histo changes): erythema in photodistributed pattern, facial oedema, epidermal necrosis
Nonspecific: reticulate telangiectasia erythema on thenar & hypothenar eminence of palms, pulps and dorsum fingers
Hyperkeratosis, ragged cuticles
Hair: 50% alopecia: diffuse or scarring, 30% coarse, dry, fragile hair.

47
Q

Significance of livedo outer arms in SLE

A

More frequently in CNS

48
Q

Risk of membranous lupus nephropathy in SLE

A

8%

49
Q

What is Senear-Usher

A

Pemphigus erythematosis (combines pemphigus + LE)
ANA +ve 80-100%
Pemphigus like Abs 80-100%
DIF: Ig and complement in intercellular substance & at dermal, epidermal junction of perilesional skin
Induced by penicillamine, captopril, propranolol

50
Q

Bullous lupus

histo

A 
subepidermal blister with Neutrophils and microabscesses.  Linear deposition of IgA, IgG and IgM, C3
Type 1 (type VII collagen), 2 (other antigens) 3 (epidermal antigens)
51
Q

Where does bullous LE occur

A

Face, neck, upper trunk

1/3 have mouth lesions

52
Q

Associations with bullous lupus

A

glomerulonephritis

Drugs eg hydralazine, IFN alpha

53
Q

T/F SLE is worse in childhood

A

T

54
Q

SLE in elderly

A

Increase in incidence of lung disease and sjogrens
20% have onset >60
Decrease in renal and mesenteric vascultiis
Increase in HLA DR3, frequent Ro/La

55
Q

SLE in pregnancy worsens T/F

A

F

56
Q

You should avoid oestrogen containing OCPs in SLE

A

T

57
Q

Risks of SLE in pregnancy

A

Higher risk of premature delivery, feral loss and perinatal mortality. Can give AZA

58
Q

Drug induced SLE
In who
abs

A

Older, uncommon in black ppl, F>M, HLADR4, slow acetylators
Uncommon to have Ro/La
May be associated with antihistone, antiphopholipid, pANCA (minor), dsDNA (antiATNF)

59
Q

Drug induced SLE often has renal and CNS involvement T/F

A

F

60
Q

Antihistone abs in drug induced lupus - which drugs

A

Procainamide, hydralazine, chlorpromazine, quinidine (>90%)

Minocycline, propylthiouracil, statins(

61
Q

SCLE - drug induced has anti-histone abs T/F

A

F

62
Q

In drug induced SCLE, anti SSA will disappear after the drug is ceased in most ppl T/F

A

T 75% will disappear

63
Q

If C1q is present in DLE DIF what does this mean

A

Risk of eventual systemic disease

64
Q

3 key histological features of lupus

A
  1. Liquefaction degeneration of basal cell layer
  2. Degenerative changes of connective tissue - Hyalinisation, oedema, fibrinoid changes
  3. Patchy dermal infiltrate with a few plasma cells + histiocytes around appendages which may be atrophic
65
Q

What is Kikuchi-Fujimoto disease

A

histiocytic necrotising lymphadenitis,.
Idiopathic systemic inflammatory disease, typically affects cervical lymph nodes. skin changes in 30%. Associated with SLE, HHV6, Parvovirus, EBV, dengue, Yersinia

Lupus (1 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions